Related Experiment Videos
[Radiofrequency fulguration of accessory pathways]
A Fajuri1, R González, R Neghme
1Departamento de Enfermedades Cardiovasculares, Hospital Clínico, P Universidad Católica de Chile, Santiago de Chile.
Revista Medica De Chile
|June 1, 1994
Summary
Radiofrequency ablation offers a curative solution for most Wolff-Parkinson-White syndrome patients. This procedure successfully treated accessory pathways in 81% of cases, providing a safe and effective treatment option.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Wolff-Parkinson-White syndrome is characterized by accessory pathways causing arrhythmias.
- Radiofrequency ablation has emerged as a primary treatment modality.
Purpose of the Study:
- To evaluate the efficacy and safety of radiofrequency ablation for accessory pathways in patients with Wolff-Parkinson-White syndrome.
Main Methods:
- Retrospective analysis of 75 patients undergoing radiofrequency ablation between 1991 and 1993.
- Utilized retrograde aortic and right heart approaches based on pathway location (mitral annulus, tricuspid annulus).
Main Results:
- Successful ablation achieved in 61 patients (81%).
- Various accessory pathway locations were targeted, including left, posteroseptal, anteroseptal, and right-sided pathways.
- One non-ablation-related fatality (cardiac tamponade) occurred.
Conclusions:
- Radiofrequency ablation is a highly effective and curative procedure for the majority of Wolff-Parkinson-White syndrome patients.
- The study supports radiofrequency ablation as a definitive treatment for accessory pathways.